Tomosynthesis Mammographic Imaging Screening Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

3,065

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Breast Cancer
Interventions
DEVICE

Tomosynthesis

Three-dimensional imaging of both breasts in standard CC and MLO views

Trial Locations (4)

V5Z 1H4

X-Ray 505 (Under the BCCA Screening Mammography Program of BC), Vancouver

V6H 3N1

Breast Health Centre at BC Women's Hospital + Health Centre, Vancouver

K1Y 4E9

The Ottawa Hospital, Ottawa

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Eastern Cooperative Oncology Group

NETWORK

lead

Sunnybrook Health Sciences Centre

OTHER

NCT02616432 - Tomosynthesis Mammographic Imaging Screening Trial | Biotech Hunter | Biotech Hunter